🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations Raj Chakraborty 👏🏽👏🏽 for championing this through! Glad we could contribute to get this important data out! Mayo Myeloma Mayo Amyloid

A short🧵on FISH in AL #Amyloidosis and findings of our multicenter study on 283 patients with AL treated with daratumumab-based frontline therapy (Dara-VCd/Dara-Vd) Blood Journal ashpublications.org/blood/article-…

2nd annual amyloidosis patient appreciation event Mayo Clinic AZ Mayo Amyloid Mayo Clinic Transplant #patientsfirst eric steidley Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Saurabh Chhabra Martha Grogan MD Melissa Lyle #hopeishere World Amyloidosis Day

ash.confex.com/ash/2024/webpr… shameless Mayo Amyloid plug but the EMILIA trial of Dr. Muchtar's is a decentralized trial in progress asking a very important question: do we need 2 years of dara maintenance? Patients can get all their treatment locally. #ASH24 /3

ash.confex.com/ash/2024/webpr… horrible shameless plug, I should be ashamed of myself but still will do it : by Matt Rees and your truly: proteomic determinants of renal organ responses in patients achieving deep sustained heme remissions Mayo Amyloid #ASh24 /5

ash.confex.com/ash/2024/webpr… another shameless plug of intergroup trial (SWOG-led) in progress trying to definitively answer the role of ASCT in #amyloidosis by Patrick Hagen Surbhi Sidana, MD Robert Z. Orlowski Mayo Amyloid /8

Find Amyloidosis intimidating? Friday Marriott ballroom 11AM, 3 yodas of Amyloidosis will make it crystal clear. You’ll never be uncertain again #ash2024

Escape the Amyloid Maze: Unraveling Data and Care Strategies for AL Amyloidosis 🌟 📅 Friday, December 6, 2024 Join Suzanne Lentzsch, MD, PhD Morie Gertz and Vaishali Sanchorawala for an engaging satellite symposium ahead of ASH! Explore the latest in AL amyloidosis with expert insights.#ash2024

⁦Angela Dispenzieri⁩ presents ⁦ASH⁩ best practice recommendation for biopsy in diagnosis of AL Amyloidosis

#ASH24 please wellcome to oral abstract session on AL Amyloidosis today which will host MRD by the great Bruno Paiva new Mayo Amyloid classification plus new treatment approaches including and beyond ANDROMEDA

Paper (finally) out: Whole tissue proteomic analyses of cardiac ATTR and AL #amyloidosis unveil mechanisms of tissue damage.tandfonline.com/doi/full/10.10… Did not publish open access due to cost limitations so can't show figures here but main points follow:

Excited to share ⁦Mayo Clinic⁩ experience with #amyloid and🫀transplant 📌 Post tx survival #amyloid = non-amyloid pts 📌 ⬇️ wait times for #amyloid after allocation change 📌 ⬇️ multi- organ tx with TTR targeted therapies ⁦⁦Mayo Amyloid⁩ onlinelibrary.wiley.com/doi/10.1111/ct…

Most excited bout this long awaited collab! A unique, first of kind opportunity to leverage AI-powered quantum imaging to transform clinical practice & improve patient care! Mayo Amyloid Mayo Clinic CV Amyloidosis Research Consortium Mohamad Alkhouli Martha Grogan MD Peter Noseworthy, MD @drpaulfriedman

Now accepting applications for the #Amyloidosis Fellowship Mayo Amyloid. Supported by Amyloidosis Research Consortium , with the goal of training expert clinicians while fostering opportunities for clinical and translational research. For more information and to apply college.mayo.edu/academics/resi…

jobcenter.hematology.org/job/14561

Great work by Matthew Rees on proteomic determinants of renal response in AL #amyloidosis pubmed.ncbi.nlm.nih.gov/39972595/ (need institutional access unfortunately). We looked at the plaque proteome of patients with renal AL who achieved at least sustained heme VGPR 1/

Lack of RCT data on ASCT in AL Amyloidosis (+ ⬆️ TRM vs myeloma) makes decisions tough when VGPR/CR post-DaraVCd. This new TRM risk model by Eli Muchtar ⁦Mayo Amyloid⁩ will help us better weigh risks/benefits in clinic! ⁦⁦CAMP@CUIMC⁩ search.app/z6SjVNVXqTrmeX…

IT'S TIME! The 2nd Annual #ATTR Early-Career Research Forum abstract submission window is open! Submit here for a chance to win $100,000: cornerstonemeded.com/attr-ecrf/ Submission Deadline: October 17th Please share this opportunity with your network of friends and colleagues!

Please share this exciting and interactive Amyloid case based seminar w/your fellow Amyloid champions and trainees. Brett Sperry, MD Mazen Hanna Melissa Lyle Martha Grogan MD Ahmad Masri Yevgeniy Brailovsky DO MSc FACC Michelle Kittleson MD PhD Ronald Witteles Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Kevin Alexander

The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy - Kidney International Nattawat Klomjit ⁦fernando fervenza⁩ ⁦Sanjeev Sethi⁩ kidney-international.org/article/S0085-…